Logo-aim
Arch Iran Med. 2022;25(3): 161-165. doi: 10.34172/aim.2022.27

Original Article

A Report on Drug Resistance Patterns of Mycobacterium tuberculosis Isolates in Northern Iran

Noormohamad Mansoori 1 * ORCID, Bagher Pahlavanzadeh 2, Masoumeh Atarjalali 3

Cited by CrossRef: 1


1- Ibnouf S, Esenkaya Taşbent F. Resistance Rates of Mycobacterium tuberculosis Complex Isolates to Primary Anti-tuberculosis Drugs: A 5-Year Retrospective Study. 2024;34(2):190 [Crossref]
2- Mansoori N, Pahlavanzadeh B, Atarjalali M. Risk factors associated with multidrug-resistant tuberculosis in areas with a moderate tuberculosis burden. 2024; [Crossref]
3- Ayoubi S, Farnia P, Farnia P, Ghanavi J, Velayati A. Prevalence and Temporal Trends of Multidrug-resistant Tuberculosis in Iran from 1981 to 2023: A Systematic Review and Meta-analysis. 2024;13(3):320 [Crossref]


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.